BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 18339795)

  • 1. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.
    Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Datta Gupta S; Bahadur S; Siu KW
    Mol Cell Proteomics; 2008 Jun; 7(6):1162-73. PubMed ID: 18339795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
    Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
    J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy.
    Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Dattagupta S; Thakar A; Chauhan SS; Siu KW
    J Proteome Res; 2009 Jan; 8(1):300-9. PubMed ID: 19072117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and verification of gelsolin as a potential biomarker of colorectal adenocarcinoma in the Chinese population: Examining differential protein expression using an iTRAQ labelling-based proteomics approach.
    Fan NJ; Gao CF; Wang CS; Lv JJ; Zhao G; Sheng XH; Wang XL; Li DH; Liu QY; Yin J
    Can J Gastroenterol; 2012 Jan; 26(1):41-7. PubMed ID: 22288069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear S100A7 is associated with poor prognosis in head and neck cancer.
    Tripathi SC; Matta A; Kaur J; Grigull J; Chauhan SS; Thakar A; Shukla NK; Duggal R; DattaGupta S; Ralhan R; Siu KW
    PLoS One; 2010 Aug; 5(8):e11939. PubMed ID: 20689826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry.
    DeSouza LV; Grigull J; Ghanny S; Dubé V; Romaschin AD; Colgan TJ; Siu KW
    Mol Cell Proteomics; 2007 Jul; 6(7):1170-82. PubMed ID: 17374602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomic analysis of formalin-fixed and paraffin-embedded nasopharyngeal carcinoma using iTRAQ labeling, two-dimensional liquid chromatography, and tandem mass spectrometry.
    Xiao Z; Li G; Chen Y; Li M; Peng F; Li C; Li F; Yu Y; Ouyang Y; Xiao Z; Chen Z
    J Histochem Cytochem; 2010 Jun; 58(6):517-27. PubMed ID: 20124091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
    Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
    Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach.
    Wang LN; Tong SW; Hu HD; Ye F; Li SL; Ren H; Zhang DZ; Xiang R; Yang YX
    J Cell Biochem; 2012 Dec; 113(12):3762-72. PubMed ID: 22807371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome.
    Marimuthu A; Chavan S; Sathe G; Sahasrabuddhe NA; Srikanth SM; Renuse S; Ahmad S; Radhakrishnan A; Barbhuiya MA; Kumar RV; Harsha HC; Sidransky D; Califano J; Pandey A; Chatterjee A
    Biochim Biophys Acta; 2013 Nov; 1834(11):2308-16. PubMed ID: 23665456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and quantification of preterm birth biomarkers in human cervicovaginal fluid by liquid chromatography/tandem mass spectrometry.
    Shah SJ; Yu KH; Sangar V; Parry SI; Blair IA
    J Proteome Res; 2009 May; 8(5):2407-17. PubMed ID: 19271751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential LC-MS-based proteomics of surgical human cholangiocarcinoma tissues.
    Kawase H; Fujii K; Miyamoto M; Kubota KC; Hirano S; Kondo S; Inagaki F
    J Proteome Res; 2009 Aug; 8(8):4092-103. PubMed ID: 19569727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry.
    Bai Y; Wang J; Gao Z; Dai E
    Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance.
    Masui O; White NM; DeSouza LV; Krakovska O; Matta A; Metias S; Khalil B; Romaschin AD; Honey RJ; Stewart R; Pace K; Bjarnason GA; Siu KW; Yousef GM
    Mol Cell Proteomics; 2013 Jan; 12(1):132-44. PubMed ID: 23082029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
    Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
    Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of calcium binding protein S100 A7 (psoriasin) in laryngeal carcinoma.
    Tiveron RC; de Freitas LC; Figueiredo DL; Serafini LN; Mamede RC; Zago MA
    Braz J Otorhinolaryngol; 2012; 78(4):59-65. PubMed ID: 22936138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iTRAQ-based quantitative proteomic analysis on S100 calcium binding protein A2 in metastasis of laryngeal cancer.
    Zha C; Jiang XH; Peng SF
    PLoS One; 2015; 10(4):e0122322. PubMed ID: 25874882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
    Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
    J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copy number gain and oncogenic activity of YWHAZ/14-3-3zeta in head and neck squamous cell carcinoma.
    Lin M; Morrison CD; Jones S; Mohamed N; Bacher J; Plass C
    Int J Cancer; 2009 Aug; 125(3):603-11. PubMed ID: 19405126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.